Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Anxiety and caffeine consumption in people with anxiety disorders.

Lee MA, Cameron OG, Greden JF.

Psychiatry Res. 1985 Jul;15(3):211-7.

2.

Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not.

Masdrakis VG, Papakostas YG, Vaidakis N, Papageorgiou C, Pehlivanidis A.

Depress Anxiety. 2008;25(9):E72-9.

PMID:
17427182
3.

Caffeine abstention in the management of anxiety disorders.

Bruce MS, Lader M.

Psychol Med. 1989 Feb;19(1):211-4.

PMID:
2727208
4.

Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders.

Mathew RJ, Wilson WH.

Acta Psychiatr Scand. 1990 Jul;82(1):17-22.

PMID:
2399815
5.

Caffeine consumption in hospitalized psychiatric patients.

Rihs M, Muller C, Baumann P.

Eur Arch Psychiatry Clin Neurosci. 1996;246(2):83-92.

PMID:
9063913
6.

Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence.

Boulenger JP, Uhde TW, Wolff EA 3rd, Post RM.

Arch Gen Psychiatry. 1984 Nov;41(11):1067-71.

PMID:
6497568
7.

Caffeine consumption and anxiety and depressive symptomatology among medical students.

Mino Y, Yasuda N, Fujimura T, Ohara H.

Arukoru Kenkyuto Yakubutsu Ison. 1990 Dec;25(6):486-96.

PMID:
2085289
8.

Anxiety, type A behavior, and cardiovascular disease.

Lee MA, Cameron OG.

Int J Psychiatry Med. 1986-1987;16(2):123-9.

PMID:
3744680
9.

Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Silverman K, Evans SM, Strain EC, Griffiths RR.

N Engl J Med. 1992 Oct 15;327(16):1109-14.

10.

The ability of the Symptom Checklist SCL-90 to differentiate various anxiety and depressive disorders.

Kennedy BL, Morris RL, Pedley LL, Schwab JJ.

Psychiatr Q. 2001 Fall;72(3):277-88.

PMID:
11467161
11.

The SCL-90-R as a screening instrument for severe personality disturbance among outpatients with mood and anxiety disorders.

Starcevic V, Bogojevic G, Marinkovic J.

J Pers Disord. 2000 Fall;14(3):199-207.

PMID:
11019744
12.

Development of the stress response inventory and its application in clinical practice.

Koh KB, Park JK, Kim CH, Cho S.

Psychosom Med. 2001 Jul-Aug;63(4):668-78.

PMID:
11485121
13.

Caffeine: use and effects in long-stay psychiatric patients.

Mayo KM, Falkowski W, Jones CA.

Br J Psychiatry. 1993 Apr;162:543-5.

PMID:
8481748
14.
15.

Caffeine and caffeinism.

Mackay DC, Rollins JW.

J R Nav Med Serv. 1989 Summer;75(2):65-7.

PMID:
2607498
16.

Caffeine consumption and anxiety: preliminary results of a survey comparing patients with anxiety disorders and normal controls.

Boulenger JP, Uhde TW.

Psychopharmacol Bull. 1982 Oct;18(4):53-7. No abstract available.

PMID:
7156298
17.

[Validation of a scale for responsibility (Salkovskis Responsibility Scale)].

Bouvard M, Robbe-Grillet P, Milliery M, Pham S, Amireche S, Fanget F, Guerin J, Cottraux J.

Encephale. 2001 May-Jun;27(3):229-37. French.

PMID:
11488253
18.

The frequency of the psychiatric symptoms in the patients with dyspepsia at a university hospital.

Guz H, Sunter AT, Bektas A, Doganay Z.

Gen Hosp Psychiatry. 2008 May-Jun;30(3):252-6. doi: 10.1016/j.genhosppsych.2008.02.003.

PMID:
18433657
19.

Effectiveness of mindfulness-based cognitive therapy as an adjuvant to pharmacotherapy in patients with panic disorder or generalized anxiety disorder.

Kim YW, Lee SH, Choi TK, Suh SY, Kim B, Kim CM, Cho SJ, Kim MJ, Yook K, Ryu M, Song SK, Yook KH.

Depress Anxiety. 2009;26(7):601-6. doi: 10.1002/da.20552.

PMID:
19242985
20.

Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders.

Koh KB, Kim CH, Park JK.

J Clin Psychiatry. 2002 Jun;63(6):486-92.

PMID:
12088159

Supplemental Content

Support Center